Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials von Strimpakos, Alexios S, Sharma, Ricky A

Volltext

The molecular targets for the diagnosis and treatment of pancreatic cancer von Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad Wasif

Volltext

Update on phase I studies in advanced pancreatic adenocarcinoma. Hunting in darkness? von Strimpakos, Alexios S, Saif, Muhammad Wasif

Volltext

Percentage Change in Plasma Cytokeratin 18 Is Associated with Clinical Outcomes in Patients Receiving Pemetrexed and Carboplatin for the Adenocarcinoma Subtype of NSCLC von Strimpakos, Alexios S., Banerji, Udai, Thavasu, Parames, Tsilimagou, Alexandra, Psyrri, Amanta, Syrigos, Kostas N.

Volltext

The Role of Endobronchial Ultrasound in Lung Cancer Diagnosis and Staging: A Comprehensive Review von Kokkonouzis, Ioannis, Strimpakos, Alexios S, Lampaditis, Ioannis, Tsimpoukis, Sotirios, Syrigos, Kostas N

Volltext

The Efficacy of Gemcitabine as Salvage Treatment in Patients with Refractory Advanced Colorectal Cancer (CRC): A Single Institution Experience von MUHAMMAD WASIF SAIF, KALEY, Kristin, PENNEY, Robin, HOTCHKISS, Susan, SYRIGOS, Kostas N, STRIMPAKOS, Alexios S

Volltext

Azithromycin Pulses for the Treatment of Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption: An Effective and Convenient Alternative to Tetracyclines von Nikolaou, Vasiliki, Strimpakos, Alexios S., Stratigos, Alexander, Katsambas, Andreas, Antoniou, Christina, Syrigos, Kostas N.

Volltext

Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implications von Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad Wasif

Volltext

Translational research. New findings and potential future applications in pancreatic adenocarcinoma von Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad Wasif

Volltext

Novel agents in early phase clinical studies on refractory pancreatic cancer von Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad Wasif

Volltext

Clinical and laboratory biomarkers in the management of pancreatic adenocarcinoma von Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad Wasif

Volltext

Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer von Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad W

Volltext

Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress? von Ramfidis, Vassilios S, Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad W

Volltext

Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009 von Strimpakos, Alexios S, Syrigos, Kostas N, Saif, Muhammad Wasif

Volltext

Therapeutic tools in pancreatic cancer von Hoimes, Christopher J, Strimpakos, Alexios S, Saif, Muhammad Wasif

Volltext

Pancreatic cancer: translating lessons from mouse models von Strimpakos, Alexios S, Hoimes, Christopher, Saif, Muhammad Wasif

Volltext

Erlotinib (E) in non small cell lung cancer (NSCLC) patients (pts) ≥75 years old with comorbidities (cM): Experience at a tertiary referral center von Syrigos, Konstantinos N., Sarris, Evangelos, Strimpakos, Alexios S

Volltext

Bevacizumab (Bv) in non small cell lung cancer (NSCLC) patients ≥75 years old with pre-existing cardiovascular disease (CVD): Experience at a tertiary referral center von Strimpakos, Alexios S, Vassos, Demetrios, Panagiotarakou, Meropi, Syrigos, Konstantinos N.

Volltext

Clinical characteristics, diagnosis, treatment, and prognosis in lung cancer patients under the age of 45 von Makrilia, Nektaria, Strimpakos, Alexios S, Gkiozos, Ioannis, Syrigos, Kostas N

Volltext

Cytology- versus histology-based diagnosis in small cell lung cancer: Is there any clinical implication? von Strimpakos, Alexios S, Ramfidis, Vassilios, Maragkos, Charilaos, Panagiotarakou, Meropi, Gkiozos, Ioannis, Syrigos, Kostas N

Volltext